Stocksigma LogoStocksigma Logo

CORONA Remedies Board to Consider Q2 and H1 Results on 30th Oct'26

CORONA Remedies Limited has scheduled a Board of Directors meeting on 30th Oct'26 to consider and approve the standalone and consolidated unaudited

CORONA Remedies Board to Consider Q2 and H1 Results on 30th Oct'26

Corona Remedies Ltd 路 Intimation 路 30 Oct 2026, 5:30 am

CORONA Remedies Board to Consider Q2 and H1 Results on 30th Oct'26 CORONA Remedies Limited has scheduled a Board of Directors meeting on 30th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed until 1st Nov'26 pursuant to insider trading regulations.

Original exchange filing (PDF)

More announcements from Corona Remedies Ltd

All Corona Remedies Ltd announcements